5 Cheap NASDAQ Stocks To Buy

4. Viatris Inc. (NASDAQ:VTRS)

Forward Price To Earnings Ratio: 3.19

Number of Hedge Fund Investors In Q2 2023: 42

Viatris Inc. (NASDAQ:VTRS) is a healthcare company that develops treatments for cancer, skin diseases, immune system disorders, and other ailments. Its third quarter results announced in November 2023 saw net sales remain flat and operating income drop by 4%.

By the end of Q2 2023, 42 out of the 910 hedge funds polled by Insider Monkey were the firm’s investors. Viatris Inc. (NASDAQ:VTRS)’s biggest investor out of these is Stephen Dubois’ Camber Capital Management as it owns 22.5 million shares that are worth $224 million.

Follow Viatris Inc